France's Cisbio Bioassays Targets Korea And China Sales Markets
This article was originally published in PharmAsia News
Executive Summary
SEOUL - French Cisbio Biassays will target South Korea and China as new sales markets in Asia as the countries are becoming two of the fastest-emerging pharmaceutical and biotechnology markets, according to Cisbio Bioassays executives